DePuy Launches New Interbody Implant For Degenerative Disc Disease
DePuy Synthes, an orthopedic and neurosurgery company owned by Johnson & Johnson, recently announced the launch of their new flagship technology, the CONCORDE LIFT Interbody Implant. The new implantable device was designed to help treat patients suffering from degenerative disc disease, a condition that can cause extreme pain from a damaged disc in the spine.
The implantable device was designed as part of a new procedural solution that can simplify minimally invasive spine surgery procedures used to help restore disc height in the spinal column. This is typically done through the process of spinal fusion, a surgical pr...
Source: MDDI - August 20, 2018 Category: Medical Devices Authors: Kristopher Sturgis Tags: Orthopedics Source Type: news
BoneSupport wins Canadian approval for Cerament G bone graft substitute
BoneSupport said today it won Health Canada approval for its Cerament G bone graft substitute.
The Lund, Sweden-based company touted it as the first and only CE Marked gentamicin-eluting injectable ceramic bone graft substitute on the market.
Bonesupport said it is currently engaged in a trial of Cerament G exploring it’s ability to improve standard-of-care management of patients with open fractures of the tibial diaphysis. The study is slated to enroll 230 patients at 30 centers in the US and Europe, with primary endpoints including the absence of deep infection at the fracture site and a lack of secondary procedur...
Source: Mass Device - August 17, 2018 Category: Medical Devices Authors: Fink Densford Tags: Orthopedics Regulatory/Compliance Bonesupport Source Type: news
Return to play among elite basketball players after osteochondral allograft transplantation of full-thickness cartilage lesions - Balazs GC, Wang D, Burge AJ, Sinatro AL, Wong AC, Williams RJ.
BACKGROUND: Osteochondral allograft transplantation (OCA) is a recognized option for full-thickness articular cartilage defects of the knee, especially in the setting of large lesions or those involving the subchondral bone. Previous heterogenous studies o... (Source: SafetyLit)
Source: SafetyLit - August 17, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Doxycycline with bone graft for lateral sinus lift?
Have any of you used doxycycline with bone graft for a lateral sinus lift?The postDoxycycline with bone graft for lateral sinus lift? appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - August 15, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Questions Regenerative Source Type: news
Bone graft at the time of implant placement or earlier?
I am getting conflicting advice regarding whether to graft at the time of implant placement to improve the emergence profile or graft earlier and then later place the implant.The postBone graft at the time of implant placement or earlier? appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - August 14, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Cases Regenerative Surgical Source Type: news
Wright Medical shares rise on Q2 earnings Beat
Shares in Wright Medical (NSDQ:WMGI) rose today in pre-market trading after the medical device maker beat expectations on Wall Street with its second quarter results.
The Amsterdam-based company posted losses of $67.7 million, or 64¢ per share, on sales of $205.4 million for the three months ended July 1, seeing losses grow 64.5% while sales grew 14.3% compared with the same period last year.
Adjusted to exclude one-time items, losses per share were 3¢, just ahead of the 6¢ loss-per-share consensus on The Street, where analysts were looking for sales of $196.8 million, which the company also topped.
“We produced ...
Source: Mass Device - August 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat wrightmedical Source Type: news
7 medtech stories we missed this week: August 3, 2018
[Image from unsplash.com]From Esaote launching its new ultrasound device to Nipro’s Infraredx launching in Japan, here are seven medtech stories we missed this week but thought were still worth mentioning.
1. Esaote launches new ultrasound devices
Esaote announced in an Aug. 2 press release that it has launched its new MyLab X7, MyLab X6 and MyLab X5 ultrasound systems. The MyLab X7 offers faster and more reliable ultrasounds with intuitive usability and ergonomics. MyLab X5 has zero-click automatic that speeds up assessments and enhances image quality.
2. Bonesupport inks deal with MTF Biologics
Bonesupport and MT...
Source: Mass Device - August 3, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Catheters Diagnostics Food & Drug Administration (FDA) Hospital Care Imaging Regulatory/Compliance Software / IT Ultrasound Bonesupport Esaote InfraReDx Inc. ivwatch MedTech Mindshare Medical Modulated Imaging MTF Bi Source Type: news
Can you re-sterilise unused portions of synthetic bone graft material?
If I have large portions of unused synthetic graft material like CaSO4 or bTCP, can I re-sterilize it?The postCan you re-sterilise unused portions of synthetic bone graft material? appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - July 31, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Questions Regenerative Source Type: news
Cerapedics launches P-15L peptide-enhanced bone graft IDE trial
Cerapedics said today it launched a new investigational device exemption trial looking to explore the safety and efficacy of its next-gen P-15L peptide enhanced bone graft in transforaminal interbody fusion surgeries.
The Westminster, Colo.-based company said it has enrolled the first patients in the study, which aims to enroll a total of 364 patients with degenerative disk disease at 30 sites across the US.
“We are pleased to announce enrollment of the first patients in our IDE study in TLIF procedures. More than 300,000 people in the U.S. suffer from degenerative disk disease that leads to pain and nerve irritatio...
Source: Mass Device - July 30, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Orthopedics Cerapedics Inc. Source Type: news
7 medtech stories we missed this week: July 27, 2018
[Image from unsplash.com]From the FDA clearing LifeSignal’s wireless ECG to Zavation receiving FDA clearance for its expandable corpectomy cage, here are seven medtech stories we missed this week but thought were still worth mentioning.
1. FDA clears LifeSignal’s wireless ECG
LifeSignals announced in a July 26 press release that it has received FDA clearance for its wireless LP1100 Life Signal Patch. The patch is designed to be used in wearables and healthcare monitoring devices. The clearance allows the company to use the Life Signal Processor to develop ECG and other vital sign monitoring wearables with wir...
Source: Mass Device - July 27, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Diagnostics Food & Drug Administration (FDA) Hospital Care Imaging Patient Monitoring Prosthetics Regulatory/Compliance DoseOptics FBC Device Flashback Technologies Health.io LifeSignal Medi-Lynx Cardiac Monitoring MedTe Source Type: news
Osseous distraction: alternative to grafting?
Do you think that osseous distraction can be used as an alternative to bone grafts?The postOsseous distraction: alternative to grafting? appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - July 26, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Questions Surgical Source Type: news
Bioventus Sheds its BMP Business For Undisclosed Sum
Bioventus is divesting its next generation bone morphogenetic protein (BMP) development program to a newly formed by Viscogliosi Brothers LLC for an undisclosed sum. The deal is expected to close in late Q318.
When completed, Bioventus will receive an equity stake in the new company formed by Viscogliosi Brothers that will work on the BMP program. In addition, Bioventus will have an observational board seat to follow the progress being made as the work continues. The parties have agreed not to disclose the sale price.
“Divesting the BMP program gives us the opportunity to increase the R&D investment in other areas o...
Source: MDDI - July 24, 2018 Category: Medical Devices Authors: Omar Ford Tags: Orthopedics Business Source Type: news
3D Printer of PEKK Implants Expanding in Asia
After receiving accreditation as a foreign medical device manufacturer by the Japanese Ministry of Health, Labour, and Welfare, Oxford Performance Materials Inc. (OPM) has forged a partnership to establish manufacturing and marketing in Japan. Known for its 3D printed PEKK OsteoFab implants, its contract manufacturing services, and its OXPEKK materials technology, OPM has partnered with Tokyo-based materials supplier JSR Corp. (JSR) to form OPM Asia. The OPM Asia license includes Japan, China, Taiwan, Korea, Brunei Darussalam, Cambodia, Lao PDR, Malaysia, Myanmar, Philippines, Singapore, Thailand, Vietnam, and India. Manuf...
Source: MDDI - July 20, 2018 Category: Medical Devices Authors: Daphne Allen Tags: 3-D Printing Source Type: news
Medtronic agrees to $43m deal to settle shareholder Infuse lawsuit
Medtronic (NYSE:MDT) shareholders are seeking approval for a $43 million settlement deal to clear up claims related to its Infuse bone graft product, according to court documents.
Shareholders in the case allege that Fridley, Minn.-based Medtronic engaged “in a scheme and course of conduct to defraud the investing public” in regards to clinical trials of the Infuse bone graft to inflate stock prices.
Plaintiffs in the case filed a class action complaint in November 2013, according to court documents, and after a protracted dispute said they believe a settlement is the best move for the class.
“Plaintiffs...
Source: Mass Device - July 20, 2018 Category: Medical Devices Authors: Fink Densford Tags: Legal News Orthopedics Medtronic Source Type: news
Bioengineering technique created for personalized bone grafts
Combining segments of bone engineered from stem cells, scientists have developed a technique for personalized bone grafts for patients with disease of injury. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 18, 2018 Category: Consumer Health News Source Type: news
